OVARIAN

(Ovarian Cancer Survival Data)

Data:

   futime fustat     age resid.ds rx ecog.ps
1      59      1 72.3315        2  1       1
2     115      1 74.4932        2  1       1
3     156      1 66.4658        2  1       2
4     421      0 53.3644        2  2       1
5     431      1 50.3397        2  1       1
6     448      0 56.4301        1  1       2
7     464      1 56.9370        2  2       2
8     475      1 59.8548        2  2       2
9     477      0 64.1753        2  1       1
10    563      1 55.1781        1  2       2
11    638      1 56.7562        1  1       2
12    744      0 50.1096        1  2       1
13    769      0 59.6301        2  2       2
14    770      0 57.0521        2  2       1
15    803      0 39.2712        1  1       1
16    855      0 43.1233        1  1       2
17   1040      0 38.8932        2  1       2
18   1106      0 44.6000        1  1       1
19   1129      0 53.9068        1  2       1
20   1206      0 44.2055        2  2       1
21   1227      0 59.5890        1  2       2
22    268      1 74.5041        2  1       2
23    329      1 43.1370        2  1       1
24    353      1 63.2192        1  2       2
25    365      1 64.4247        2  2       1
26    377      0 58.3096        1  2       1

Description:

Survival in a randomised trial comparing two treatments for ovarian cancer

Format:

futime:	 survival or censoring time
fustat:	 censoring status
age:	 in years
resid.ds:	 residual disease present (1=no,2=yes)
rx:	 treatment group
ecog.ps:	 ECOG performance status (1 is better, see reference)

Source:

Terry Therneau

References:

Edmunson, J.H., Fleming, T.R., Decker, D.G., Malkasian, G.D., Jefferies, J.A., Webb, M.J., and Kvols, L.K., Different Chemotherapeutic Sensitivities and Host Factors Affecting Prognosis in Advanced Ovarian Carcinoma vs. Minimal Residual Disease. Cancer Treatment Reports, 63:241-47, 1979.

for ECOG performance status: http://ecog.org/general/perf_stat.html

Model the surviving.